Storelli, Loredana
,
Rocca, Maria A.
Pantano, Patrizia
Pagani, Elisabetta
De Stefano, Nicola
Tedeschi, Gioacchino
Zaratin, Paola
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Funding for this research was provided by:
Fondazione Italiana Sclerosi Multipla (FISM2018/S/3)
Article History
Received: 26 June 2019
Revised: 12 August 2019
Accepted: 13 August 2019
First Online: 17 August 2019
Compliance with ethical standards
:
: L Storelli, P. Pantano, E. Pagani, G. Tedeschi, and P. Zaratin have nothing to disclose. M.A. Rocca received speaker’s honoraria from Biogen Idec, Novartis, Genzyme, Sanofi-Aventis, Teva, Merck Serono, and Roche and receives research support from the Italian Ministry of Health and Fondazione Italiana Sclerosi Multipla. N. De Stefano has received honoraria from Schering, Biogen Idec, Teva, Novartis, Genzyme, and Merck Serono S.A. for consulting services, and speaking and travel support. He serves on advisory boards for Biogen-Idec Merck Serono S.A. and Novartis. M. Filippi is Editor-in-Chief of the Journal of Neurology; received compensation for consulting services and/or speaking activities from Biogen Idec, Merck Serono, Novartis, Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck Serono, Novartis, Teva Pharmaceutical Industries, Roche, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).
: Ethical approval was received from the local ethical standards committee of each participating Center, and written informed consent was obtained from all participants at the time of data acquisition.